Global Bioburden Testing Market – Industry Trends and Forecast to 2024


Posted February 14, 2017 by ravikantdubey

Global bioburden testing market is expected to reach USD 907.4 million by 2024 from USD 452.6 million in 2016, at a CAGR of 9.1% in the forecast period 2017 to 2024.

 
Global Bioburden Testing Market, By Test Type (Aerobic, Anaerobic, Fungi, Spore), By Product Type (Instruments (PCR, Automated Microbial Identification Systems, Microscopes, Others), Consumables (Kits & Strips, Reagents, Others), By Technology (Microbial Filter Method, Advanced Colorimetric Method, Plate Count Method, Rapid Testing), By Application (Raw Material Testing, In-Process Testing, Medical Device Testing, Pharmaceutical & Cosmetic Testing, Food and Beverage Testing), By End-User (Pharmaceutical, Biotechnology, Industrial, Food & Beverages), By Geography (North America, Europe, Asia-Pacific, South America and Middle East Asia) – Industry Trends and Forecast to 2024

Download Sample Pages https://databridgemarketresearch.com/reports/bioburden-testing-market-industry-trends-and-forecast-to-2024/

Market Scenario:
The global bioburden testing market is segmented on the basis of test type, product type, technology, application, end-user, and geography.
Based on the test type the bioburden testing market is segmented into aerobic, anaerobic, fungi and spore count. The bioburden testing market segment is further categorized on the basis of product type into instruments and consumable. On the basis of end users Health Clubs, Gyms, Home Settings, Corporate Settings, Apartments, Hotels, Hospitals, Clinics.

Based on the technology microbial filter method, advanced colorimetric method and plate count method. The plate count method and membrane filtration method can be used to analyze the number of microbes in sample; the sample is passing through a filter with a pore size of 0.45 micrometers or less.

On the basis of geography the market is segmented into 5 geographical regions, North America, South America, Europe, Asia-Pacific and Middle East and Africa. The regions are further segmented into 15 chief countries such as US, Mexico, Canada, India, China, Japan, Korea, Southeast Asia, and Brazil.

Read more: https://databridgemarketresearch.com/bioburden-testing-market-poised-grow-9-1/

Company Scenario:
Major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes company share data for different geographies including Global, North America, Europe and APAC.

The global players operating in the market are Charles River Laboratories International, Inc., Pacific Bio labs, Inc., Sigma-Aldrich Corporation, SGS S.A., WuXi PharmaTech Inc., Becton, Dickinson and Company, Merck & Co., Inc., Charles River Laboratories International Inc., North American Science Associates, Inc. (NAMSA), Nelson Laboratories, Inc., Dynatec Labs, and ATS Labs, Inc. among others..

Contact:
Data Bridge Market Research
4th Floor, Mega Center,
Magarpatta City, Pune – 411028
Tel: +1-888-387-2818
Email: [email protected]
Visit Data Bridge Blog@ http://databridgemarketresearch.com/blog/
LinkedIn: https://www.linkedin.com/company/data-bridge-market-research
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By Data Bridge Market Research
Website https://databridgemarketresearch.com/reports/bioburden-testing-market-industry-trends-and-forecast-to-2024/
Phone +1-888-387-2818
Business Address 4th Floor, Mega Center, Magarpatta City, Pune – 411028
Country India
Categories Health , Medical
Tags automated microbial identification systems , fungi , in vitro diagnostics , instruments
Last Updated February 14, 2017